Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Aridis Pharmaceuticals, Inc. | 884,600 | reported | 24 Jun 2024 | tx 8+800,461−28,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 24 Jun 2024 | PURCHASE | Aridis Pharmaceuticals, Inc. | 714,286 | 0.07 USD | first after silence |
| 18 Sept 2023 | GRANT_AWARD | Aridis Pharmaceuticals, Inc. | 15,000 | 0.00 USD | deriv |
| 05 Jun 2023 | EXERCISE | Aridis Pharmaceuticals, Inc. | 12,000 | — | |
| 04 May 2023 | GRANT_AWARD | Aridis Pharmaceuticals, Inc. | 30,000 | 0.00 USD | deriv |
| 05 Jun 2023 | EXERCISE | Aridis Pharmaceuticals, Inc. | 12,000 | — | deriv |
| 05 Dec 2022 | GRANT_AWARD | Aridis Pharmaceuticals, Inc. | 24,000 | 0.00 USD | deriv |
| 27 Jul 2021 | PURCHASE | Aridis Pharmaceuticals, Inc. | 5,175 | 4.84 USD | |
| 22 Dec 2020 | GIFT | Aridis Pharmaceuticals, Inc. | 16,000 | 0.00 USD |
1 purchase reported after at least 12 months of silence — most recent on 24 Jun 2024.